Results 171 to 180 of about 759,762 (298)

Surgical Pharmacy for Optimizing Medication Therapy Management Services within Enhanced Recovery after Surgery (ERAS^®) Programs. [PDF]

J Clin Med, 2023
Xie J, Huang X, Gao M, Wei L, Wang R, Chen J, Zeng Y, Ji B, Liu T, Wang J, Wu H, Wang Y, Qin L, Wang Y, Zheng Z, Xue J, Wu J, Chen X, Zheng Z, Li X.   +19 more
europepmc   +1 more source

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin, Haocheng Yang, Feng Liu, Sihao Lin, Junru Hu, Jian Wang, Yulan Gou   +6 more
wiley   +1 more source

Bibliometric and visual analysis of medication therapy management from 2003 to 2023. [PDF]

Medicine (Baltimore)
Guo Z, Fu L, Chu Z, Gao S, Lu L, Jiao W.
europepmc   +1 more source

Impact of medication therapy management (MTM) service model on multi-morbidity (MMD) patients with hypertension: a pilot RCT. [PDF]

BMC Geriatr, 2023
Li N, Song JF, Zhang MZ, Lv XM, Hua HL, Chang YL.   +5 more
europepmc   +1 more source

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic, Ida Erngren, Kim Kultima, Anders Larsson, Malin Müller, Anna Wiberg, Joachim Burman   +6 more
wiley   +1 more source

Evaluating the Impact of the Medication Therapy Management Program on Patients' Blood Pressure and Obesity: A Pre-Post Study. [PDF]

J Prim Care Community Health
Zare H, Amuta AC, Rodriguez de Bittner M, Osotimehin S, Thomas L, Stokes TM, Allen A, Riley J, Murphy CL, Collier DM, Thorpe RJ, Spencer M, Dankwa L, Carter EL, Gaskin DJ.   +14 more
europepmc   +1 more source

Medication-Related Problems and Interventions Identified and Addressed by Pharmacists Conducting Enhanced Medication Therapy Management Services. [PDF]

Pharmacy (Basel), 2022
Knockel LE, Kim Y, Kent K, Doucette WR.
europepmc   +1 more source

Portable Low‐Field Magnetic Resonance Imaging in People With Human Immunodeficiency Virus

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aging population of people with HIV (PWH) raises heightened concerns regarding accelerated aging and dementia. Portable, low‐field MRI (LF‐MRI) is an innovative technology that could enhance access and facilitate routine monitoring of PWH.
Annabel Sorby‐Adams, Malachi Keo, Jennifer Guo, Daire Daly, Richard Ahern, Kimon Zachary, Gregory Robbins, Rajesh T. Gandhi, Bragi Sveinsson, Adam de Havenon, Kevin N. Sheth, Otto Rapalino, Juan Eugenio Iglesias Gonzales, W. Taylor Kimberly, Shibani S. Mukerji   +14 more
wiley   +1 more source

A coordinated approach for managing polypharmacy among children with medical complexity: rationale and design of the Pediatric Medication Therapy Management (pMTM) randomized controlled trial. [PDF]

BMC Health Serv Res, 2023
Orth LE, Feudtner C, Kempe A, Morris MA, Colborn KL, Gritz RM, Linnebur SA, Begum A, Feinstein JA.   +8 more
europepmc   +1 more source

Prescriptions for Excellence in Health Care Spring 2011 Download PDF [PDF]

, 2011

core   +1 more source